VEGF vascularization pathway in human intervertebral disc does not change during the disc degeneration process

被引：12

作者：

Capossela S. ^{[1
]}

Bertolo A. ^{[1
]}

Gunasekera K. ^{[1
]}

Pötzel T. ^{[2
]}

Baur M. ^{[2
,3
]}

Stoyanov J.V. ^{[1
]}

机构：

[1] Biomedical Laboratories, Swiss Paraplegic Research, Nottwil

[2] Swiss Paraplegic Centre, Nottwil

[3] Cantonal Hospital of Lucerne, Lucerne

来源：

BMC Research Notes | / 11卷 / 1期

关键词：

FLT1; Intervertebral disc; Vascularization; VEGFR1;

D O I：

10.1186/s13104-018-3441-3

中图分类号：

学科分类号：

摘要：

Objective: During degeneration of the intervertebral disc ingrowth of blood vessels and nerves into the disc are associated with back pain. Vascular endothelial growth factors promote vasculogenesis by binding to the membrane vascular endothelial growth factor receptor 1, while shorter soluble forms of this receptor can inhibit vascularization. We hypothesized that membrane and soluble receptor forms might change between stages of intervertebral disc degeneration. Results: Expression of soluble and membrane forms of vascular endothelial growth factor receptor 1 in human degenerated intervertebral discs and healthy bovine caudal discs was assessed by qRT-PCR and immunoblot. Comparative microarray meta-analysis across disc degeneration grades showed that membrane and soluble forms of this receptor, together with other components of classic vascularization pathways, are constitutively expressed across human disc degeneration stages. Contrary to our hypothesis, we observed that expression of the classic vascularization pathway is stable across degeneration stages and we assume that soluble vascular endothelial growth factor receptor 1 does not contribute to prevent disc degeneration. However, we observed increased expression levels of genes involved in alternative vascularization signalling pathways in severely degenerated discs, suggesting that abnormal vascularization is part of the pathological progression of disc degeneration. © 2018 The Author(s).

引用

共 42 条

[1] Raj P.P., Intervertebral disc: Anatomy-physiology-pathophysiology-treatment, Pain Pract, 8, pp. 18-44, (2008)
[2] Urban J.P., Smith S., Fairbank J.C., Nutrition of the intervertebral disc, Spine (Phila Pa 1976), 29, pp. 2700-2709, (2004)
[3] Johnson W.E., Caterson B., Eisenstein S.M., Hynds D.L., Snow D.M., Roberts S., Human intervertebral disc aggrecan inhibits nerve growth in vitro, Arthritis Rheum, 46, pp. 2658-2664, (2002)
[4] Johnson W.E., Caterson B., Eisenstein S.M., Roberts S., Human intervertebral disc aggrecan inhibits endothelial cell adhesion and cell migration in vitro, Spine (Phila Pa 1976), 30, pp. 1139-1147, (2005)
[5] Urban J.P., Roberts S., Degeneration of the intervertebral disc, Arthritis Res Ther, 5, pp. 120-130, (2003)
[6] Stefanakis M., Al-Abbasi M., Harding I., Pollintine P., Dolan P., Tarlton J., Adams M.A., Annulus fissures are mechanically and chemically conducive to the ingrowth of nerves and blood vessels, Spine (Phila Pa 1976), 37, pp. 1883-1891, (2012)
[7] Haro H., Kato T., Komori H., Osada M., Shinomiya K., Vascular endothelial growth factor (VEGF)-induced angiogenesis in herniated disc resorption, J Orthop Res, 20, pp. 409-415, (2002)
[8] Cebe-Suarez S., Zehnder-Fjallman A., Ballmer-Hofer K., The role of VEGF receptors in angiogenesis
[9] Complex partnerships, Cell Mol Life Sci, 63, pp. 601-615, (2006)
[10] Kendall R.L., Thomas K.A., Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor, Proc Natl Acad Sci USA, 90, pp. 10705-10709, (1993)

← 1 2 3 4 5 →